Abstract
Monocyte chemoattractant protein-1 (MCP-1), a member of the C-C subfamily of chemokines, is important for the local recruitment of leukocytes to sites of inflammatory challenge. Here, we investigated endothelial signaling pathways involving members of the mitogen-activated protein (MAP) kinase superfamily and studied their role for MCP-1 expression in endothelium. We show that tumor necrosis factor-alpha (TNF-alpha), a potent inflammatory activator of endothelium, leads to activation of MAP kinases ERK, p38, and JNK in human umbilical vein endothelial cells (HUVEC). Contribution of MAP kinase pathways to TNF-alpha-induced synthesis of endothelial MCP-1 was then studied by pharmacologic inhibition and transient expression of dominant negative or constitutively active kinase mutants using flow cytometry, Northern blot, and luciferase reporter gene assays. Inhibition of Raf/MEK/ERK or SEK/JNK pathways had no significant effect on MCP-1 levels, whereas blocking the MKK6/p38 pathway by p38 inhibitors SB203580 or SB202190 or by a dominant negative mutant of MKK6, the upstream activator of p38, strongly inhibited TNF-alpha-induced expression of MCP-1. Consistent with that finding, expression of wild-type or constitutively active MKK6 significantly enhanced the effect of limiting TNF-alpha concentrations on MCP-1 synthesis. These data suggest a crucial role for the MKK6/p38 stress kinase cascade in TNF-alpha-mediated endothelial MCP-1 expression.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Calcium-Calmodulin-Dependent Protein Kinases / antagonists & inhibitors
-
Calcium-Calmodulin-Dependent Protein Kinases / genetics
-
Calcium-Calmodulin-Dependent Protein Kinases / metabolism
-
Calcium-Calmodulin-Dependent Protein Kinases / physiology*
-
Cells, Cultured
-
Chemokine CCL2 / biosynthesis*
-
Chemokine CCL2 / genetics
-
Endothelium, Vascular / cytology
-
Endothelium, Vascular / metabolism*
-
Enzyme Activation
-
Enzyme Inhibitors / pharmacology
-
Gene Expression Regulation / drug effects*
-
Humans
-
Imidazoles / pharmacology
-
JNK Mitogen-Activated Protein Kinases
-
MAP Kinase Kinase 6
-
Mitogen-Activated Protein Kinase 3
-
Mitogen-Activated Protein Kinases*
-
Multigene Family
-
Pyridines / pharmacology
-
RNA, Messenger / biosynthesis
-
Recombinant Fusion Proteins / biosynthesis
-
Recombinant Fusion Proteins / physiology
-
Signal Transduction / physiology*
-
Stress, Physiological / physiopathology*
-
Tumor Necrosis Factor-alpha / pharmacology*
-
p38 Mitogen-Activated Protein Kinases
Substances
-
Chemokine CCL2
-
Enzyme Inhibitors
-
Imidazoles
-
Pyridines
-
RNA, Messenger
-
Recombinant Fusion Proteins
-
Tumor Necrosis Factor-alpha
-
Calcium-Calmodulin-Dependent Protein Kinases
-
JNK Mitogen-Activated Protein Kinases
-
Mitogen-Activated Protein Kinase 3
-
Mitogen-Activated Protein Kinases
-
p38 Mitogen-Activated Protein Kinases
-
MAP Kinase Kinase 6
-
MAP2K6 protein, human
-
SB 203580
-
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole